Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Current Models for Development of Disease-Modifying Osteoarthritis Drugs
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current Models for Development of Disease-Modifying Osteoarthritis Drugs'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Disease-modifying Osteoarthritis Drugs (DMOADs)
100%
Osteoarthritis
50%
Osteoarthritis Model
37%
Clinical Application
25%
Microphysiological Systems
25%
Clinical Trials
12%
Clinically Significant
12%
Should Be Given
12%
Response to Treatment
12%
Drug Development
12%
Long-term Efficacy
12%
Drug Efficacy
12%
Personalized Medicine
12%
Drug pipeline
12%
Model-driven Development
12%
Human Trials
12%
Microphysiological
12%
On-a-chip
12%
Disabling Conditions
12%
Regulatory Bodies
12%
Drug Safety
12%
Artificial Knee Joint
12%
New Platform
12%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Drug Development
100%
Drug Efficacy
50%
Drug Safety
50%
Deficiency
50%
Medicine and Dentistry
Osteoarthritis
100%
Diseases
100%
Clinical Trial
20%
Ex Vivo
10%
Personalized Medicine
10%
In Vitro
10%
Knee Joint
10%
Drug Safety
10%
Pharmacology, Toxicology and Pharmaceutical Science
Osteoarthritis
100%
Diseases
100%
Clinical Trial
20%
Drug Development
20%
Drug Safety
10%